Trial intelligence / Profile preview

Phase 3 antidiabetic agent trial in Japan (drug unspecified)

jRCT2080222923Phase 3Completed

Start
Jul 2015
Countries
1
01

Overview

Phase 3 trial in type 2 diabetes mellitus (T2DM). Started Jul 2015; status: completed.

02

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080222923.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222923.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call